|
FAM164A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.585600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.476500E-02 |
| Normal-vs-Stage2 |
6.828800E-01 |
| Normal-vs-Stage3 |
2.594500E-04 |
| Normal-vs-Stage4 |
9.28940000033407E-07 |
| Stage1-vs-Stage2 |
3.276800E-01 |
| Stage1-vs-Stage3 |
2.523800E-02 |
| Stage1-vs-Stage4 |
4.449500E-04 |
| Stage2-vs-Stage3 |
2.136400E-02 |
| Stage2-vs-Stage4 |
6.976400E-03 |
| Stage3-vs-Stage4 |
5.671000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.440120E-03 |
| Normal-vs-AfricanAmerican |
6.612900E-04 |
| Normal-vs-Asian |
3.703400E-01 |
| Caucasian-vs-AfricanAmerican |
2.410000E-01 |
| Caucasian-vs-Asian |
8.237400E-01 |
| AfricanAmerican-vs-Asian |
4.374400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.040500E-04 |
| Normal-vs-Female |
1.334340E-02 |
| Male-vs-Female |
3.833600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.917700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.477200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.561000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.565000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.129200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.854600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.260200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.068400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.171600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.961000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.775400E-01 |
| Normal-vs-Grade 2 |
1.978990E-01 |
| Normal-vs-Grade 3 |
2.37510000000718E-06 |
| Normal-vs-Grade 4 |
5.90410054179813E-10 |
| Grade 1-vs-Grade 2 |
2.547400E-01 |
| Grade 1-vs-Grade 3 |
2.986400E-02 |
| Grade 1-vs-Grade 4 |
2.955400E-03 |
| Grade 2-vs-Grade 3 |
1.140670E-03 |
| Grade 2-vs-Grade 4 |
2.10460000538149E-08 |
| Grade 3-vs-Grade 4 |
4.247800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.626200E-01 |
| Normal-vs-ccB subtype |
7.59040000000155E-05 |
| ccA subtype-vs-ccB subtype |
3.60710000000264E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.115880E-02 |
| Normal-vs-N1 |
9.80130000000079E-05 |
| N0-vs-N1 |
1.815370E-03 |
|
|
